IP Library Assignment 014237/0019
Patent Assignment
Reel/Frame 014237/0019

Assignment of Assignor's Interest

Recorded: 2003-07-07 Pages: 4
Assignor
ELAN PHARMACEUTICALS, INC.
Executed: 2003-05-30
Assignee
JONES PHARMA INCORPORATED
510 CUMBERLAND STREET, SUITE 200, BRISTOL, VIRGINIA, 24201
Covered Property (1)
Method for Increasing the Bioavailability of Metaxalone
Patent: 6,683,102 →
Application: 10/104,044 →
Publication: US 2003/0216457
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger and Change of Name Mar 6, 2007
From: JONES PHARMA INCORPORATED
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC
Reel/Frame 018961/0829 →
Security Agreement Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
Release of Security Interest May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →
Security Agreement May 13, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 025703/0628 →
Release of Security Interest Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025738/0132 →